These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6940687)

  • 21. Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.
    Kufe DW; Spriggs DR; Griffin JD
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):149-58. PubMed ID: 3473675
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
    Potter CG; Bunch C
    Br J Cancer; 1980 Jun; 41(6):985-8. PubMed ID: 6932908
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell proliferation and protein synthesis in human leukaemic myeloblasts after cytosine arabinoside therapy.
    Wantzin GL; Karle H; Killmann SA
    Br J Haematol; 1976 Feb; 32(2):283-9. PubMed ID: 1061618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract]   [Full Text] [Related]  

  • 25. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
    Gandhi V; Xu YZ; Estey E
    Clin Cancer Res; 1998 Jul; 4(7):1719-26. PubMed ID: 9676847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential advances in the clinical use of arabinosyl cytosine.
    Ho DH
    Cancer Treat Rep; 1977 Jul; 61(4):717-22. PubMed ID: 267509
    [No Abstract]   [Full Text] [Related]  

  • 27. Two simple high-performance liquid chromatographic methods for simultaneous determination of 2'-deoxycytidine 5'-triphosphate and cytosine arabinoside 5'-triphosphate concentrations in biological samples.
    Danks MK
    J Chromatogr; 1982 Dec; 233():141-8. PubMed ID: 7161328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ara-C metabolism: implications for drug resistance and drug interactions.
    Chabner BA; Hande KR; Drake JC
    Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells.
    Muus P; Drenthe-Schonk A; Haanen C; Wessels H; Linssen P
    Leuk Res; 1987; 11(4):319-25. PubMed ID: 3470578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cytosine arabinoside triphosphate on the incorporation of 3H-thymidine in mitochondria isolated from HeLa cells.
    Mattoccia LP; Sorrentino R
    J Cell Physiol; 1979 Oct; 101(1):17-23. PubMed ID: 541351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and cellular pharmacology of cytosine arabinoside.
    Kufe DW; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):34-48. PubMed ID: 3925560
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
    Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
    Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.
    Wiley JS; Jones SP; Sawyer WH; Paterson AR
    J Clin Invest; 1982 Feb; 69(2):479-89. PubMed ID: 6948829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
    Chou TC; Arlin Z; Clarkson BD; Phillips FS
    Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
    Riva CM; Rustum YM; Preisler HD
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):1-8. PubMed ID: 3859925
    [No Abstract]   [Full Text] [Related]  

  • 37. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
    Laliberté J; Marquez VE; Momparler RL
    Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of cytosine arabinoside in Tetrahymena pyriformis.
    Benhura MA
    Comp Biochem Physiol B; 1985; 80(4):821-5. PubMed ID: 3922672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.
    Onetto N; Momparler RL; Momparler LF; Gyger M
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):231-7. PubMed ID: 2438776
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the cytotoxicity of cytosine arabinoside.
    Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.